Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
Australian Clinical Labs Ltd
Australian Clinical Labs Ltd
ACL · ASX

Australian Clinical Labs Ltd

AU$2.61

0.00 (0.00%)
06/11/2025 03:59:59 PM
All-CompaniesAll-ConsensusConsensus CheapGROWTH AUSHALO Capital EfficiencyHALO OrdsHALO SmallHALO Value+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Australian Clinical Labs Ltd Overview

ACL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Weak

Garp

Neutral

Mqv Small

Weak

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Neutral

About ACL

icon

Website

Australian Clinical Labs Ltd

icon

Telephone

61.13.0045.3688

icon

Address

1868-1892 Dandenong Road, Clayton, Victoria (VIC) 3168

Description

Australian Clinical Labs Ltd. engages in the provision of pathology services. It operates through the Pathology segment. The Pathology segment includes pathology/clinical laboratory services provided in Australia. The company was founded in 2015 and is headquartered in Clayton, Australia.

ACL Price Chart

Key Stats

Market Cap

AU$524.72M

PE

14.00

EV/EBITDA

2.7

Dividends Overview

DIV Yield

4.3%

Franking

100%

Ex Dividend Date (est.)

01-Sep-25

Market Data

52 weeks range

Low 2.38 - 3.83

Trade Value (12mth)

AU$639,646.00

1 week

0.38%

1 month

4.4%

YTD

-23.68%

1 year

-28.88%

All time high

6.39

Key Fundamentals

EPS 3 yr Growth

-80.60%

EBITDA Margin

27.00%

Operating Cashflow

$183m

Free Cash Flow Return

49.80%

ROIC

8.80%

Interest Coverage

10.80

Quick Ratio

0.50

Other Data

Shares Outstanding (Fully Diluted)

194m

HALO Sector

Healthcare

Next Company Report Date

26-Aug-26

Next Ex Dividend Date

01-Sep-25

Next Dividend Pay Date

23-Sep-25

Reporting Currency

AUD

Short Sell (% of issue)

0.00

ACL Announcements

Latest Announcements

DateAnnouncements
06 November 25
28 October 25
24 October 25
23 October 25
23 October 25

ACL Fundamentals

Per Share Records

Historical data

Forecast data

AUD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock0.180.120.17locklocklock
EPS (Fully Diluted)
$locklocklocklock0.180.120.17locklocklock
Growth
%locklocklocklock-79.8-32.842.6locklocklock
PE
Xlocklocklocklock15.517.714locklocklock
EV/EBITDA
Xlocklocklocklock3.53.12.7locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

01-Sep-25

DIV Yield

4.3%

Franking Level

100%

DPSg

4.2%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

Short Selling

Key Stats

Percent of Issue

3.55%

Value ($M)

17

Prior Change

0

7 Day Change

0.30%

1 Month Change

0.80%

3 Months Change

0.60%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ACL Shortsell

Want to learn more?Frequently asked questions.
What is the current share price of Australian Clinical Labs Ltd (ACL:ASX)?
Halo FAQ
The current share price of Australian Clinical Labs Ltd (ACL:ASX) is AUD$2.61.
What is the 52-week high share price for Australian Clinical Labs Ltd (ACL:ASX)?
Halo FAQ
The 52-week high share price for Australian Clinical Labs Ltd (ACL:ASX) is AUD$3.83.
What is the 52-week low share price for Australian Clinical Labs Ltd (ACL:ASX)?
Halo FAQ
The 52-week low share price for Australian Clinical Labs Ltd (ACL:ASX) is AUD$2.38.
What is the dividend yield for Australian Clinical Labs Ltd (ACL:ASX)?
Halo FAQ
The current TTM dividend payout for Australian Clinical Labs Ltd (ACL:ASX) is 4.30.
What was Australian Clinical Labs Ltd (ACL:ASX) last dividend payment?
Halo FAQ
The last dividend payment of Australian Clinical Labs Ltd (ACL:ASX) is AUD$0.09.
What is the franking level for Australian Clinical Labs Ltd (ACL:ASX)?
Halo FAQ
Australian Clinical Labs Ltd (ACL:ASX) has a franking level of 100.00%.
In which sector is Australian Clinical Labs Ltd (ACL:ASX) classified?
Halo FAQ
Australian Clinical Labs Ltd (ACL:ASX) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Australian Clinical Labs Ltd (ACL:ASX)?
Halo FAQ
The current P/E ratio for Australian Clinical Labs Ltd (ACL:ASX) is 14.00.

See beyond the curve.

One solution for research, investing and portfolio management.